Product Information
ONDANSETRON HCL 4 MG/2 ML VIAL is a generic product labeled by Baxter Healthcare Corporation, priced at $0.1759 per ML under NDC 36000001225. Its NADAC has been published 355 times since Jan 23, 2019.
FDA first approved this application on Feb 22, 2013. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Baxter Healthcare CorporationNDC
36000001225
Classification
Generic
Dosage Form
SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078287FDA Approved
2/22/2013
TE Code
AP
On Market Since
3/13/2013
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has been published 355 times since Jan 23, 2019, and over the history we have for it it has declined 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1759 per ML |
|---|---|
| All-time high | $0.2695 (Sep 14, 2022) |
| All-time low | $0.1702 (Aug 18, 2021) |
| 52-week high | $0.2112 |
| 52-week low | $0.1759 |
| Median price | $0.2008 |
| Average price | $0.2104 |
| Largest weekly change | +41.9% (Jan 18, 2023) |
| Weeks tracked | 355 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ONDANSETRON HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Baxter Healthcare Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ONDANSETRON HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON HCL 4 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 4 MG/2 ML VIAL, manufactured by Baxter Healthcare Corporation, is $0.1759 per ML (NDC 36000001225), effective Sep 30, 2026.
How has the price of ONDANSETRON HCL 4 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has declined 30.7%. It has been tracked across 355 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 4 MG/2 ML VIAL?
Since Jan 23, 2019, the NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has ranged from a low of $0.1702 (Aug 18, 2021) to a high of $0.2695 (Sep 14, 2022), with a median of $0.2008 per ML.
Are there cheaper alternatives to ONDANSETRON HCL 4 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of ONDANSETRON HCL 4 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ONDANSETRON HCL 4 MG/2 ML VIAL?
ONDANSETRON HCL 4 MG/2 ML VIAL (NDC 36000001225) is labeled by Baxter Healthcare Corporation, and CMS classifies it as a generic product.